Lisa Turner

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Gene Expression

Mild Cognitive Impairment

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas M Goralski, Lindsay Meyerdirk, Libby Breton, Laura Brasseur, Kevin Kurgat, Daniella DeWeerd, Lisa Turner, Katelyn Becker, Marie Adams, Daniel J Newhouse, Michael X Henderson
Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology. Nature communications 15 (1) (2024)
Thomas M Goralski, Lindsay Meyerdirk, Libby Breton, Laura Brasseur, Kevin Kurgat, Daniella DeWeerd, Lisa Turner, Katelyn Becker, Marie Adams, Daniel J Newhouse, Michael X Henderson
Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology. Nature communications 15 (1) (2024)
Thomas M Goralski, Lindsay Meyerdirk, Libby Breton, Laura Brasseur, Kevin Kurgat, Daniella DeWeerd, Lisa Turner, Katelyn Becker, Marie Adams, Daniel J Newhouse, Michael X Henderson
Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology. Nature communications 15 (1) (2024)
Thomas M Goralski, Lindsay Meyerdirk, Libby Breton, Laura Brasseur, Kevin Kurgat, Daniella DeWeerd, Lisa Turner, Katelyn Becker, Marie Adams, Daniel J Newhouse, Michael X Henderson
Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology. Nature communications 15 (1) (2024)
Thomas M Goralski, Lindsay Meyerdirk, Libby Breton, Laura Brasseur, Kevin Kurgat, Daniella DeWeerd, Lisa Turner, Katelyn Becker, Marie Adams, Daniel J Newhouse, Michael X Henderson
Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology. Nature communications 15 (1) (2024)
Jamie L Grit, Matt G Pridgeon, Curt J Essenburg, Emily Wolfrum, Zachary B Madaj, Lisa Turner, Julia Wulfkuhle, Emanuel F Petricoin, Carrie R Graveel, Matthew R Steensma
Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities. Genes 11 (3) (2020)